Treatment News : Increased Cytokine Levels in Semen May Aid in HIV Transmission

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » March 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 4, 2013

Increased Cytokine Levels in Semen May Aid in HIV Transmission

The concentration of the cytokine interleukin 7 (IL-7) in the semen of HIV-positive men may be a crucial factor that determines the virus’s transmission during vaginal intercourse. Publishing their findings in the Open Access journal PLOS Pathogens, researchers at the Eunice Kennedy-Shriver National Institute of Child Health and Human Development cultured explants of cervical and vaginal tissue in their lab that allowed them to simulate HIV transmission outside the human body.

Cytokines are proteins that help modulate immune responses. HIV infection tends to greatly increase the concentration of IL-7 in semen. So the researchers added concentrations of IL-7 comparable to those found in HIV-positive men to the tissue culture and found that HIV not only transmitted more readily but also replicated at higher levels than it did without the presence of IL-7.

The cytokine slows the death of HIV-infected cells and also stimulates CD4 cell proliferation—two reasons why the study’s authors speculate that IL-7, along with other cytokines, may be a key factor determining rates of HIV transmission. Differences in cytokine levels in semen, they argue, may be the reason for varying rates of HIV transmission between individuals.

A similar study conducted in a clinical setting is needed, the researchers state. Also, research should determine if those who have been treated with IL-7 to increase their CD4 count may have in turn become more infectious because of concentrations of the cytokine in their semen. The study also suggests that a new HIV prevention strategy may one day target seminal cytokines.

To read the press release in ScienceDaily, click here.

To read the study, click here.

Search: Cytokine, semen, interleukin 7, IL-7, PLOS Pathogens, Eunice Kennedy-Shriver National Institute of Child Health and Human Development.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         


[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.